Pfizer, BioNTech, and Regeneron Hit With Patent Lawsuits Over COVID-19 Drugs and VaccinesThe Motley Fool • 10/05/20
Regeneron Pharmaceuticals, Gilead Sciences Shares Rise As Their Therapies Used To Treat PresidentInvestors Business Daily • 10/05/20
Gilead, Regeneron, Amgen: Covid Treatment Stocks Still Worth Looking At As Vaccine Nears?Forbes • 10/02/20
2 Regeneron Analysts On COVID-19 Antibody Cocktail's Emergency Use Authorization ProspectsBenzinga • 09/30/20
Covid Report: Regeneron, Moderna, CureVac Up As Possible Coronavirus Cures AdvanceInvestors Business Daily • 09/30/20
Regeneron Says COVID-19 Antibody Cocktail Helped Non-Hospitalized Patients Heal Faster In Early TrialsBenzinga • 09/30/20
Regeneron Pharmaceutical Posts Positive Initial Data On Its Covid-19 TreatmentInvestors Business Daily • 09/29/20
Regeneron says that trial coronavirus drug cocktail cut virus load, aided patient recoveryMarket Watch • 09/29/20
Scott+Scott Attorneys at Law LLP Continues Investigating Regeneron Pharmaceuticals, Inc.'s Directors and Officers for Breach of Fiduciary Duty - REGNPRNewsWire • 09/29/20